{"entity":{"type":"insider","cik":"0001838061","url":"/insider/0001838061","json_url":"/insider/0001838061.json","name":"Michaelson Jennifer","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":52,"n_filings":40,"first":"2021-08-24","last":"2026-08-14","span_basis":"filed_date"},"name_variants":[{"name":"Michaelson Jennifer","source":"filing","n_filings":40,"first_seen":"2021-08-24","last_seen":"2026-08-14"}],"transactions":[{"id":9255681,"accession":"0001193125-26-352523","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-352523","line_url":"/filing/0001193125-26-352523#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":20.26,"price_display":"20.26","price_state":"stated","total_value":607800.0,"total_display":"607,800.00","total_whole":"607,800","shares_owned_after":162844.0,"shares_owned_after_display":"162,844","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-13","filed_date":"2026-08-14","scope":"insider"},{"id":6006307,"accession":"0001193125-26-297605","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-297605","line_url":"/filing/0001193125-26-297605#line-2","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":17.82,"price_display":"17.82","price_state":"stated","total_value":142560.0,"total_display":"142,560.00","total_whole":"142,560","shares_owned_after":162844.0,"shares_owned_after_display":"162,844","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-06","filed_date":"2026-07-07","scope":"insider"},{"id":6153686,"accession":"0001193125-26-209307","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-209307","line_url":"/filing/0001193125-26-209307","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":14.6245,"price_display":"14.62","price_state":"stated","total_value":116996.0,"total_display":"116,996.00","total_whole":"116,996","shares_owned_after":167044.0,"shares_owned_after_display":"167,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-05","filed_date":"2026-05-06","scope":"insider","n_lines":2},{"id":5770829,"accession":"0001193125-26-098781","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-098781","line_url":"/filing/0001193125-26-098781#line-2","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":15.68,"price_display":"15.68","price_state":"stated","total_value":125440.0,"total_display":"125,440.00","total_whole":"125,440","shares_owned_after":170844.0,"shares_owned_after_display":"170,844","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-05","filed_date":"2026-03-09","scope":"insider"},{"id":6036489,"accession":"0001193125-26-077259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-077259","line_url":"/filing/0001193125-26-077259#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1780.0,"shares_display":"1,780","price_per_share":14.14,"price_display":"14.14","price_state":"stated","total_value":25169.2,"total_display":"25,169.20","total_whole":"25,169","shares_owned_after":174844.0,"shares_owned_after_display":"174,844","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-25","filed_date":"2026-02-26","scope":"insider"},{"id":6229029,"accession":"0001193125-26-072002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-072002","line_url":"/filing/0001193125-26-072002#line-2","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3601.0,"shares_display":"3,601","price_per_share":14.47,"price_display":"14.47","price_state":"stated","total_value":52106.47,"total_display":"52,106.47","total_whole":"52,106","shares_owned_after":176624.0,"shares_owned_after_display":"176,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-24","filed_date":"2026-02-25","scope":"insider"},{"id":6229025,"accession":"0001193125-26-072002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-072002","line_url":"/filing/0001193125-26-072002#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1752.0,"shares_display":"1,752","price_per_share":13.99,"price_display":"13.99","price_state":"stated","total_value":24510.48,"total_display":"24,510.48","total_whole":"24,510","shares_owned_after":180225.0,"shares_owned_after_display":"180,225","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-25","scope":"insider"},{"id":5847126,"accession":"0001193125-26-064256","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-064256","line_url":"/filing/0001193125-26-064256","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11742.0,"shares_display":"11,742","price_per_share":14.083294157724408,"price_display":"14.08","price_state":"stated","total_value":165366.04,"total_display":"165,366.04","total_whole":"165,366","shares_owned_after":181977.0,"shares_owned_after_display":"181,977","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-20","filed_date":"2026-02-23","scope":"insider","n_lines":2},{"id":6228761,"accession":"0001193125-26-051700","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-051700","line_url":"/filing/0001193125-26-051700#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":416.0,"shares_display":"416","price_per_share":12.03,"price_display":"12.03","price_state":"stated","total_value":5004.48,"total_display":"5,004.48","total_whole":"5,004","shares_owned_after":128219.0,"shares_owned_after_display":"128,219","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-12","filed_date":"2026-02-13","scope":"insider"},{"id":6110973,"accession":"0001193125-26-021225","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-021225","line_url":"/filing/0001193125-26-021225#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":12.3,"price_display":"12.30","price_state":"stated","total_value":49200.0,"total_display":"49,200.00","total_whole":"49,200","shares_owned_after":128635.0,"shares_owned_after_display":"128,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-22","filed_date":"2026-01-23","scope":"insider"},{"id":5026722,"accession":"0001193125-25-328909","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-328909","line_url":"/filing/0001193125-25-328909#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1345.0,"shares_display":"1,345","price_per_share":10.01,"price_display":"10.01","price_state":"stated","total_value":13463.45,"total_display":"13,463.45","total_whole":"13,463","shares_owned_after":132635.0,"shares_owned_after_display":"132,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-19","filed_date":"2025-12-22","scope":"insider"},{"id":5183804,"accession":"0001193125-25-327027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-327027","line_url":"/filing/0001193125-25-327027#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2898.0,"shares_display":"2,898","price_per_share":9.67,"price_display":"9.67","price_state":"stated","total_value":28023.66,"total_display":"28,023.66","total_whole":"28,024","shares_owned_after":133980.0,"shares_owned_after_display":"133,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-18","filed_date":"2025-12-19","scope":"insider"},{"id":4906740,"accession":"0001193125-25-321122","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-321122","line_url":"/filing/0001193125-25-321122#line-2","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":995.0,"shares_display":"995","price_per_share":11.9,"price_display":"11.90","price_state":"stated","total_value":11840.5,"total_display":"11,840.50","total_whole":"11,841","shares_owned_after":136878.0,"shares_owned_after_display":"136,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-15","filed_date":"2025-12-16","scope":"insider"},{"id":4906737,"accession":"0001193125-25-321122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-321122","line_url":"/filing/0001193125-25-321122#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2148.0,"shares_display":"2,148","price_per_share":12.38,"price_display":"12.38","price_state":"stated","total_value":26592.24,"total_display":"26,592.24","total_whole":"26,592","shares_owned_after":137873.0,"shares_owned_after_display":"137,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-12","filed_date":"2025-12-16","scope":"insider"},{"id":4298577,"accession":"0001193125-25-297549","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-297549","line_url":"/filing/0001193125-25-297549#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":12.3,"price_display":"12.30","price_state":"stated","total_value":49200.0,"total_display":"49,200.00","total_whole":"49,200","shares_owned_after":138004.0,"shares_owned_after_display":"138,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-24","filed_date":"2025-11-25","scope":"insider"},{"id":4194215,"accession":"0000950170-25-029200","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-029200","line_url":"/filing/0000950170-25-029200#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3756.0,"shares_display":"3,756","price_per_share":8.53,"price_display":"8.53","price_state":"stated","total_value":32038.68,"total_display":"32,038.68","total_whole":"32,039","shares_owned_after":142004.0,"shares_owned_after_display":"142,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-25","filed_date":"2025-02-27","scope":"insider"},{"id":4524581,"accession":"0000950170-25-002946","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-002946","line_url":"/filing/0000950170-25-002946#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":12.51,"price_display":"12.51","price_state":"stated","total_value":50040.0,"total_display":"50,040.00","total_whole":"50,040","shares_owned_after":95760.0,"shares_owned_after_display":"95,760","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-07","scope":"insider"},{"id":2350886,"accession":"0000950170-24-139125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-139125","line_url":"/filing/0000950170-24-139125#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4693.0,"shares_display":"4,693","price_per_share":11.41,"price_display":"11.41","price_state":"stated","total_value":53547.13,"total_display":"53,547.13","total_whole":"53,547","shares_owned_after":99760.0,"shares_owned_after_display":"99,760","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-18","filed_date":"2024-12-20","scope":"insider"},{"id":2125898,"accession":"0000950170-24-136726","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-136726","line_url":"/filing/0000950170-24-136726#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3489.0,"shares_display":"3,489","price_per_share":12.52,"price_display":"12.52","price_state":"stated","total_value":43682.28,"total_display":"43,682.28","total_whole":"43,682","shares_owned_after":104453.0,"shares_owned_after_display":"104,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-12","filed_date":"2024-12-16","scope":"insider"},{"id":2073412,"accession":"0000950170-24-123538","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-123538","line_url":"/filing/0000950170-24-123538#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":15.64,"price_display":"15.64","price_state":"stated","total_value":125120.0,"total_display":"125,120.00","total_whole":"125,120","shares_owned_after":107942.0,"shares_owned_after_display":"107,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-05","filed_date":"2024-11-07","scope":"insider"},{"id":2305970,"accession":"0000950170-24-104820","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-104820","line_url":"/filing/0000950170-24-104820#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":18.09,"price_display":"18.09","price_state":"stated","total_value":144720.0,"total_display":"144,720.00","total_whole":"144,720","shares_owned_after":115942.0,"shares_owned_after_display":"115,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-05","filed_date":"2024-09-09","scope":"insider"},{"id":2037476,"accession":"0000950170-24-082485","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-082485","line_url":"/filing/0000950170-24-082485#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":16.33,"price_display":"16.33","price_state":"stated","total_value":130640.0,"total_display":"130,640.00","total_whole":"130,640","shares_owned_after":123942.0,"shares_owned_after_display":"123,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-05","filed_date":"2024-07-09","scope":"insider"},{"id":2895074,"accession":"0000950170-24-056093","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-24-056093","line_url":"/filing/0000950170-24-056093#line-5","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5606.0,"shares_display":"5,606","price_per_share":30.06,"price_display":"30.06","price_state":"stated","total_value":168516.36,"total_display":"168,516.36","total_whole":"168,516","shares_owned_after":129582.0,"shares_owned_after_display":"129,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-07","filed_date":"2024-05-08","scope":"insider"},{"id":2895066,"accession":"0000950170-24-056093","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-056093","line_url":"/filing/0000950170-24-056093","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58000.0,"shares_display":"58,000","price_per_share":28.07171448275862,"price_display":"28.07","price_state":"stated","total_value":1628159.44,"total_display":"1,628,159.44","total_whole":"1,628,159","shares_owned_after":149859.0,"shares_owned_after_display":"149,859","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-06","filed_date":"2024-05-08","scope":"insider","n_lines":2},{"id":8108890,"accession":"0000950170-23-072753","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-072753","line_url":"/filing/0000950170-23-072753#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1145.0,"shares_display":"1,145","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":9732.5,"total_display":"9,732.50","total_whole":"9,733","shares_owned_after":87582.0,"shares_owned_after_display":"87,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-21","filed_date":"2023-12-22","scope":"insider"},{"id":8282519,"accession":"0000950170-23-071988","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-071988","line_url":"/filing/0000950170-23-071988#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":238.0,"shares_display":"238","price_per_share":8.22,"price_display":"8.22","price_state":"stated","total_value":1956.36,"total_display":"1,956.36","total_whole":"1,956","shares_owned_after":88727.0,"shares_owned_after_display":"88,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-18","filed_date":"2023-12-20","scope":"insider"},{"id":8530868,"accession":"0000950170-23-070142","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-070142","line_url":"/filing/0000950170-23-070142#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1068.0,"shares_display":"1,068","price_per_share":7.81,"price_display":"7.81","price_state":"stated","total_value":8341.08,"total_display":"8,341.08","total_whole":"8,341","shares_owned_after":88965.0,"shares_owned_after_display":"88,965","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-12","filed_date":"2023-12-13","scope":"insider"},{"id":8040008,"accession":"0000950170-23-029160","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-029160","line_url":"/filing/0000950170-23-029160#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":238.0,"shares_display":"238","price_per_share":12.94,"price_display":"12.94","price_state":"stated","total_value":3079.72,"total_display":"3,079.72","total_whole":"3,080","shares_owned_after":90033.0,"shares_owned_after_display":"90,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-21","scope":"insider"},{"id":7801104,"accession":"0000950170-23-027984","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-027984","line_url":"/filing/0000950170-23-027984#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":176.0,"shares_display":"176","price_per_share":13.11,"price_display":"13.11","price_state":"stated","total_value":2307.36,"total_display":"2,307.36","total_whole":"2,307","shares_owned_after":90271.0,"shares_owned_after_display":"90,271","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-12","filed_date":"2023-06-14","scope":"insider"},{"id":8724177,"accession":"0000950170-23-027063","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-23-027063","line_url":"/filing/0000950170-23-027063#line-4","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":12.4,"price_display":"12.40","price_state":"stated","total_value":1240.0,"total_display":"1,240.00","total_whole":"1,240","shares_owned_after":90447.0,"shares_owned_after_display":"90,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-07","filed_date":"2023-06-08","scope":"insider"},{"id":8724173,"accession":"0000950170-23-027063","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-027063","line_url":"/filing/0000950170-23-027063#line-2","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11900.0,"shares_display":"11,900","price_per_share":12.31,"price_display":"12.31","price_state":"stated","total_value":146489.0,"total_display":"146,489.00","total_whole":"146,489","shares_owned_after":90447.0,"shares_owned_after_display":"90,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-06","filed_date":"2023-06-08","scope":"insider"},{"id":8351350,"accession":"0000899243-23-013364","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-013364","line_url":"/filing/0000899243-23-013364#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":239.0,"shares_display":"239","price_per_share":8.76,"price_display":"8.76","price_state":"stated","total_value":2093.64,"total_display":"2,093.64","total_whole":"2,094","shares_owned_after":90447.0,"shares_owned_after_display":"90,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-18","filed_date":"2023-05-19","scope":"insider"},{"id":7801052,"accession":"0000950170-23-022557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-022557","line_url":"/filing/0000950170-23-022557#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":193.0,"shares_display":"193","price_per_share":8.78,"price_display":"8.78","price_state":"stated","total_value":1694.54,"total_display":"1,694.54","total_whole":"1,695","shares_owned_after":90686.0,"shares_owned_after_display":"90,686","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-12","filed_date":"2023-05-16","scope":"insider"},{"id":8465014,"accession":"0000950170-23-013701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-013701","line_url":"/filing/0000950170-23-013701#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":238.0,"shares_display":"238","price_per_share":10.71,"price_display":"10.71","price_state":"stated","total_value":2548.98,"total_display":"2,548.98","total_whole":"2,549","shares_owned_after":90879.0,"shares_owned_after_display":"90,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-18","filed_date":"2023-04-20","scope":"insider"},{"id":8032847,"accession":"0000899243-23-011292","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-011292","line_url":"/filing/0000899243-23-011292#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":176.0,"shares_display":"176","price_per_share":10.22,"price_display":"10.22","price_state":"stated","total_value":1798.72,"total_display":"1,798.72","total_whole":"1,799","shares_owned_after":91117.0,"shares_owned_after_display":"91,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-12","filed_date":"2023-04-14","scope":"insider"},{"id":8279693,"accession":"0000899243-23-009716","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-009716","line_url":"/filing/0000899243-23-009716#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":238.0,"shares_display":"238","price_per_share":11.32,"price_display":"11.32","price_state":"stated","total_value":2694.16,"total_display":"2,694.16","total_whole":"2,694","shares_owned_after":91293.0,"shares_owned_after_display":"91,293","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-20","filed_date":"2023-03-27","scope":"insider"},{"id":6364965,"accession":"0000899243-22-037126","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-037126","line_url":"/filing/0000899243-22-037126#line-2","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":13.3,"price_display":"13.30","price_state":"stated","total_value":53200.0,"total_display":"53,200.00","total_whole":"53,200","shares_owned_after":53031.0,"shares_owned_after_display":"53,031","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-25","filed_date":"2022-11-29","scope":"insider"},{"id":6741878,"accession":"0000899243-22-032236","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-032236","line_url":"/filing/0000899243-22-032236#line-2","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":12.4,"price_display":"12.40","price_state":"stated","total_value":49600.0,"total_display":"49,600.00","total_whole":"49,600","shares_owned_after":53031.0,"shares_owned_after_display":"53,031","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-27","filed_date":"2022-09-29","scope":"insider"},{"id":6443785,"accession":"0000899243-22-028132","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-028132","line_url":"/filing/0000899243-22-028132#line-2","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1385.0,"shares_display":"1,385","price_per_share":15.01,"price_display":"15.01","price_state":"stated","total_value":20788.85,"total_display":"20,788.85","total_whole":"20,789","shares_owned_after":53031.0,"shares_owned_after_display":"53,031","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-09","scope":"insider"},{"id":6714387,"accession":"0000899243-22-026737","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-026737","line_url":"/filing/0000899243-22-026737#line-2","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":14.51,"price_display":"14.51","price_state":"stated","total_value":116080.0,"total_display":"116,080.00","total_whole":"116,080","shares_owned_after":53031.0,"shares_owned_after_display":"53,031","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-25","filed_date":"2022-07-26","scope":"insider"},{"id":4929978,"accession":"0000899243-21-040764","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-040764","line_url":"/filing/0000899243-21-040764","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":21.4173,"price_display":"21.42","price_state":"stated","total_value":85669.2,"total_display":"85,669.20","total_whole":"85,669","shares_owned_after":23515.0,"shares_owned_after_display":"23,515","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-18","filed_date":"2021-10-20","scope":"insider","n_lines":3},{"id":4405665,"accession":"0000899243-21-036782","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-036782","line_url":"/filing/0000899243-21-036782","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":24.512,"price_display":"24.51","price_state":"stated","total_value":98048.0,"total_display":"98,048.00","total_whole":"98,048","shares_owned_after":23711.0,"shares_owned_after_display":"23,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-20","filed_date":"2021-09-21","scope":"insider","n_lines":2},{"id":9205016,"accession":"0000899243-21-034312","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-034312","line_url":"/filing/0000899243-21-034312","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001838061","owner_name":"Michaelson Jennifer","owner_display_name":"Michaelson Jennifer","owner_url":"/insider/0001838061","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":27.6620225,"price_display":"27.66","price_state":"stated","total_value":110648.09,"total_display":"110,648.09","total_whole":"110,648","shares_owned_after":24048.0,"shares_owned_after_display":"24,048","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-18","filed_date":"2021-08-26","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2021-08-18|9205015","ledger_fault":false,"count":{"value":52,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":52,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":52},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001789972","name":"Cullinan Therapeutics, Inc.","url":"/issuer/0001789972","role":"Officer (Chief Scientific Officer)","n_filings":40,"first_seen":"2021-08-24","last_seen":"2026-08-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001838061","retrieved_at":"2026-08-24T10:24:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}